search
Back to results

Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients

Primary Purpose

Stroke

Status
Not yet recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
rTMS-PTi
rTMS-PTd
rTMSs-PT
Sponsored by
National Taiwan University Hospital Hsin-Chu Branch
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring rTMS, stroke

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria >=20 years old, unilateral stroke diagnosed by CT or MRI Post-stroke 1 week to 6 months Medical Research Council Scale for Muscle Strength in upper limb ≤ 3 No history of previous stroke, seizure, dementia, parkinsonism or other neurodegenerative disease stable medical condition and vital signs Exclusion criteria Previous stroke, traumatic brain injury, brain tumor With central nervous system disease (spinal cord injury, Parkinson's disease) Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker, Pregnancy...) Patients unable to cooperate the treatment

Sites / Locations

  • National Taiwan University Hospital Hsin-Chu Branch

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Sham Comparator

Arm Label

immediate rehabilitation group

delayed rehabilitation group

sham rTMS group

Arm Description

rTMS plus immediate rehabilitation programs

rTMS plus delayed rehabilitation programs

sham rTMS + rehabilitation programs

Outcomes

Primary Outcome Measures

Fugl-Meyer Assessment (FMA)
Fugl-Meyer Assessment (FMA) of upper limb

Secondary Outcome Measures

Medical Research Council (MRC) scale
Medical Research Council (MRC) scale
Grip strength
Grip strength (Kg)
Barthel Index
Barthel Index
Modified Rankin Scale
Modified Rankin Scale
maximal motor evoked potential amplitude
maximal motor evoked potential amplitude of lesion site (mV)
motor evoked potential latency
motor evoked potential latency of lesion site (ms)
resting motor threshold
bilateral resting motor threshold (mV)

Full Information

First Posted
December 9, 2022
Last Updated
December 21, 2022
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
search

1. Study Identification

Unique Protocol Identification Number
NCT05663424
Brief Title
Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients
Official Title
Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 2023 (Anticipated)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital Hsin-Chu Branch

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Comparative Efficacy of Different Time Interval between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients
Detailed Description
Stroke is one of the main causes of death and disability in Taiwan. The M1 excitability of the affected hemisphere decreases, while that of the unaffected hemisphere increases, leading to further interhemispheric inhibition. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. High and low frequencies of rTMS could modulate the excitability of the cerebral cortex. Through regulating the excitability of bilateral hemispheres, rTMS could facilitate motor recovery in stroke patients. Previous study had been demonstrated that priming rehabilitation program with low frequent rTMS would lead to better motor recovery in the chronic stroke patients. However, the optimal time interval between the rTMS and the rehabilitation program had not been investigated. Thus, this study will utilize low frequent rTMS, targeting the intact hemisphere, to investigate the clinical effects and motor cortex excitability under different time intervals between the rTMS and the rehabilitation program. This study is designed as a randomized controlled trial. We plan to recruit 45 subacute stroke patients with hemiplegia. The patients are randomly assigned to three groups. In the Group 1, the patients receive contralateral 1 Hz rTMS stimulation and subsequent rehabilitation program. In the Group 2, the patients receive contralateral 1 Hz rTMS, but the rehabilitation will be delayed at least two hours after the rTMS stimulation. The control group receive sham rTMS and subsequent rehabilitation program. The treatment schedule for all groups will be five times per week for a two-week course, which means a total of ten sessions. The primary outcome is upper limb Fugl-Meyer Assessment. The secondary outcomes included Medical Research Council (MRC) scale, Barthel Scale, Modified Rankin Scale (MRS), cortical excitability assessment (including bilateral maximum MEP amplitude, MEP latency, and bilateral resting motor threshold). Follow-up time points are before rTMS and at 1st, 4th, 12th weeks after the end of the treatments.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
rTMS, stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
45 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
immediate rehabilitation group
Arm Type
Experimental
Arm Description
rTMS plus immediate rehabilitation programs
Arm Title
delayed rehabilitation group
Arm Type
Experimental
Arm Description
rTMS plus delayed rehabilitation programs
Arm Title
sham rTMS group
Arm Type
Sham Comparator
Arm Description
sham rTMS + rehabilitation programs
Intervention Type
Other
Intervention Name(s)
rTMS-PTi
Intervention Description
10 daily sessions of rTMS (1Hz, 1200 short, for totally 20 minutes) plus immediate rehabilitation programs
Intervention Type
Other
Intervention Name(s)
rTMS-PTd
Intervention Description
10 daily sessions of rTMS (1Hz, 1200 short, for totally 20 minutes) plus delayed rehabilitation programs (>2hr)
Intervention Type
Other
Intervention Name(s)
rTMSs-PT
Intervention Description
10 daily sessions of sham rTMS (to vertex) plus rehabilitation programs
Primary Outcome Measure Information:
Title
Fugl-Meyer Assessment (FMA)
Description
Fugl-Meyer Assessment (FMA) of upper limb
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Medical Research Council (MRC) scale
Description
Medical Research Council (MRC) scale
Time Frame
12 weeks
Title
Grip strength
Description
Grip strength (Kg)
Time Frame
12 weeks
Title
Barthel Index
Description
Barthel Index
Time Frame
12 weeks
Title
Modified Rankin Scale
Description
Modified Rankin Scale
Time Frame
12 weeks
Title
maximal motor evoked potential amplitude
Description
maximal motor evoked potential amplitude of lesion site (mV)
Time Frame
12 weeks
Title
motor evoked potential latency
Description
motor evoked potential latency of lesion site (ms)
Time Frame
12 weeks
Title
resting motor threshold
Description
bilateral resting motor threshold (mV)
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria >=20 years old, unilateral stroke diagnosed by CT or MRI Post-stroke 1 week to 6 months Medical Research Council Scale for Muscle Strength in upper limb ≤ 3 No history of previous stroke, seizure, dementia, parkinsonism or other neurodegenerative disease stable medical condition and vital signs Exclusion criteria Previous stroke, traumatic brain injury, brain tumor With central nervous system disease (spinal cord injury, Parkinson's disease) Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker, Pregnancy...) Patients unable to cooperate the treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sheng-Hao Cheng, MD
Phone
0972652433
Email
shcheng1106@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Meng Ting Lin, MD
Phone
02-23123456
Ext
67048
Email
b96401093@ntu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sheng-Hao Cheng, MD
Organizational Affiliation
The Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital Hsin-Chu Branch
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Taiwan University Hospital Hsin-Chu Branch
City
Hsinchu
Country
Taiwan
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sheng-Hao Cheng, MD
Phone
0972652433
Email
shcheng1106@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients

We'll reach out to this number within 24 hrs